Cell Therapeutics gets $5 million payment from Teva for TRISENOX Cell Therapeutics, Inc. today announced that it offers received a $5 million milestone payment from Teva Pharmaceutical Sectors Ltd. TRISENOX was acquired from CTI by Cephalon, Inc. . Cephalon was acquired by Teva subsequently.Â Â.Some find this genetically altered selection of alfalfa seed as the generating force for ultimate weed control. Roundup can be sprayed en masse, choking back again nature’s eclectic array of weeds, herbs and plants that get in the way of crop production. The seed strain is definitely manufactured to resist the glyphosate in Roundup, allowing the alfalfa crops to dominate. Most of the alfalfa growing in Canada is raised in the western parts. A trial of the genetically altered alfalfa was established to end up being released in the easternmost elements of Canada, concerning not contaminate the organic alfalfa in the west, but FGI place a halt on the entire GM alfalfa endeavor in Canada.